ライフサイエンスコーパス: self-testing

1 10.7 to 36.0%]) due to increased use of HIV self-testing.

2 sibility of this strategy relies on accurate self-testing.

3 tative HIV VL testing at the POC and at home self-testing.

4 RDTs, and creating opportunities for patient self-testing.

5 t that may present an opportunity for future self-testing.

6 od-based HIV self-testing, or oral fluid HIV self-testing.

7 pletely replaced facility-based testing with self-testing.

8 for use at the point-of-care or for patient self-testing.

9 couples testing, and sexual behaviour after self-testing.

10 ntigen tests are available to the public for self-testing.

11 technologies, dried-blood-spot testing, and self-testing.

12 Using PCR as the gold standard, rapid self-testing achieved high specificity (99.1%; 95% confi

13 Our review builds on the literature for self-testing across different disease areas and demonstr

14 ate the effects of test-guidelines including self-testing advice (IV1), and the effects of self-test

15 Unitaid, through the Self-Testing Africa Initiative.

16 HIV self-testing allows HIV testing at any place and time an

17 nticoagulation-clinic care vs primary care), self-testing alone versus self-management, and sex.

18 this sweat UA assay thus encourage frequent self-testing and enhance user's compliance towards dieta

19 Participants saw the need for self-testing and found the process for the most part sim

20 Expanding home and mobile testing, self-testing and outreach to key populations with facili

21 budget impact of implementing PrEP using HIV self-testing and provider-administered rapid diagnostic

22 fects of self-monitoring or self-management (self-testing and self-dosage) of anticoagulation compare

23 Uptake of self-testing and self-management of oral anticoagulation

24 ex, key populations, campaign, workplace and self-testing) and facility approaches by population reac

25 In this study, HIV self-testing appeared to be safe and increased recent an

26 We present here an attractive on-site UA self-testing approach utilizing a touch-enabled fingerti

27 Participants in the HIV self-testing arms almost completely replaced facility-ba

28 f point-of-care INR devices to either weekly self-testing at home or monthly high-quality testing in

29 e partner HIV testing of any kind (including self-testing at home) that occurred within 30 days.

30 ncome countries (LMICs) and to enable HIV VL self-testing at home, which in turn have the potential t

31 low level of mental workload when using LFIA self-testing at home.

32 or the high-risk populations seeking private self-testing at the early stages of exposure.

33 itiated ART within the first 6 months of HIV self-testing availability.

34 not only enhances the overall reliability of self-testing but also reduces the likelihood of false-ne

35 low in the case of testing MSM ($20/LYS) and self-testing by partners of pregnant women ($130/LYS).

36 HIV self-testing can facilitate PrEP community-based deliver

37 Research indicates that self-testing can facilitate PrEP initiation and improve

38 HIV self-testing can overcome barriers to HIV testing, but i

39 Relief supported oral caregiver-assisted HIV self-testing (CG-HIVST) to address the gap in HIV diagno

40 nswer it affirmatively by providing explicit self-testing correlations for all such states.

41 HIV self-testing could play an important role in supporting

42 Frequent self-testing coupled with isolation upon awareness of fi

43 cohort study was conducted using SARS-CoV-2 self-testing data from a mandatory surveillance program

44 pala, Uganda, to measure the effect of 2 HIV self-testing delivery models on HIV testing and linkage

45 We developed a portable self-testing device that measures HIV and HCV viral load

46 ouse e-production of "ready-to-use" reliable self-testing devices.

47 monthly high-quality clinic testing, weekly self-testing did not delay the time to a first stroke, m

48 Providing a choice of HIV self-testing during delivery of door-to-door HIV testing

49 Self-testing for HIV infection may contribute to early d

50 Studies have demonstrated that self-testing for human immunodeficiency virus (HIV) is h

51 Several elements favor self-testing for large-scale implementation, including e

52 es acceptability and usability of home-based self-testing for severe acute respiratory syndrome coron

53 Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-meth

54 However, we would not recommend self-testing for urine glucose and protein without furth

55 e HIV self-testing group than in the non-HIV self-testing group (3843 [60%] of 6368 vs 3571 [55%] of

56 red with 8952 (65%) of 13 706 in the non-HIV self-testing group (adjusted odds ratio 1.30, 95% CI 1.0

57 At 2 years of follow-up, the self-testing group also had a small but significant impr

58 rated 13 267 eligible individuals in the HIV self-testing group and 13 706 in the non-HIV self-testin

59 gnificantly higher in the facility-based HIV self-testing group compared with either standard provide

60 Over the entire follow-up period, the self-testing group had a small but significant improveme

61 1063 (51%) of 2097 patients in the HIV self-testing group had HIV testing on the same day as en

62 lementation, 9027 (68%) of 13 267 in the HIV self-testing group had knowledge of HIV status compared

63 ndomization of clusters allocated to the HIV self-testing group of a parent trial.

64 r rates of clinical outcomes except that the self-testing group reported more minor bleeding episodes

65 ry event was not significantly longer in the self-testing group than in the clinic-testing group (haz

66 nowledge of HIV status was higher in the HIV self-testing group than in the non-HIV self-testing grou

67 utine door-to-door HIV testing services (HIV self-testing group) or the PopART standard of care of do

68 to-door HIV testing services alone (non- HIV self-testing group) over a 3-month period.

69 nts completed an exit survey-2097 in the HIV self-testing group, 1951 in the standard provider-initia

70 rcion was reported in the facility-based HIV self-testing group.

71 self-testing group and 13 706 in the non-HIV self-testing group.

72 emphasis on pretest counseling and that HIV self-testing has been adopted in a number of settings.

73 Human immunodeficiency virus (HIV) self-testing has emerged as a tool to increase the propo

74 Scaling up PrEP using HIV self-testing has similar health impacts, costs, and low

75 Approaches such as index testing and self-testing help to reach individuals at higher risk of

76 men than in reaching women globally, but HIV self-testing (HIVST) appears to be an acceptable alterna

77 ify which human immunodeficiency virus (HIV) self-testing (HIVST) distribution strategies are most ef

78 women aged 18-39 y were randomized to an HIV self-testing (HIVST) group or a comparison group.

79 We aimed to determine the impact of HIV self-testing (HIVST) interventions on frequency of HIV t

80 HIV self-testing (HIVST) is a promising strategy to expand t

81 Secondary distribution of HIV self-testing (HIVST) kits by patients attending clinic s

82 methods may enhance peer distribution of HIV self-testing (HIVST) kits, but interventions that can op

83 HIV self-testing (HIVST) may improve uptake of HIV services

84 HIV self-testing (HIVST) may play a role in addressing gaps

85 HIV self-testing (HIVST) provides an at-home option to count

86 its supplemented with interim home-based HIV self-testing (HIVST) versus standard of care for HIV tes

87 , and costs of community-led delivery of HIV self-testing (HIVST), aiming to increase HIV testing in

88 nvestigated a novel alternative based on HIV self-testing (HIVST).

89 The paradigm of self-testing, however, introduces new challenges, includ

90 luated the cost-effectiveness of introducing self-testing in 2015 over a 20-year time frame in a coun

91 hat is compatible with the needs of frequent self-testing in a consumer-friendly format that can link

92 ll groups by offering the choice of oral HIV self-testing in addition to routine door-to-door HIV tes

93 to a growing body of evidence on the use of self-testing in disease prevention and detection.

94 s a shortage of trials examining the role of self-testing in PrEP reinitiation, PEP initiation, or PE

95 ical trials have explored the application of self-testing in various HIV prevention strategies, inclu

96 on protocols, including regular asymptomatic self-testing, in response to the COVID-19 pandemic, the

97 Facility-based HIV self-testing increased HIV testing among outpatients in

98 HIV self-testing increases testing uptake in sub-Saharan Afr

99 collected in 2017-2019 through the HIV Oral Self-Testing Infographic Experiment study, a pilot behav

100 d controlled trial testing effects of an HIV self-testing infographic in 322 emerging adult ethnic an

101 We evaluated an HIV self-testing intervention integrated into high-burden ou

102 merated as a household member during the HIV self-testing intervention period.

103 rs have a vital role to play in adapting HIV self-testing interventions to local context.

104 he use of HIV prevention models that support self-testing is accumulating, but there is a need for fu

105 d in high HIV testing rates, indicating that self-testing is an attractive testing option for a large

106 Self-testing is an emerging approach with high acceptabi

107 HIV self-testing is an emerging innovative approach that all

108 In the intervention scenario, self-testing is introduced at a unit cost of $3.

109 Empirical research on self-testing is limited, resulting in a lack of an evide

110 he effectiveness of linkage to PrEP post HIV self-testing is mixed, underscoring the need to further

111 In the reference scenario, self-testing is not available, and the rate of first-tim

112 y criteria could lead to situations in which self-testing is not cost-effective.

113 sess whether the offer of a single, free HIV self-testing kit led to increased HIV diagnoses with lin

114 Nonetheless, the offer of a free HIV self-testing kit resulted in high HIV testing rates, ind

115 r experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by

116 AS) programme distributed around 380 000 HIV self-testing kits to key populations, including female s

117 ions in assumptions; however, higher cost of self-testing, lower linkage to care for people whose dia

118 ould home human immunodeficiency virus (HIV) self-testing make a major difference in identifying pers

119 HIV self-testing may thus be particularly useful for female

120 Existing HIV self-testing methods rely on rapid diagnostic tests (RDT

121 he possibility for nonenzymatic amperometric self-testing of glucose levels in human sweat.

122 tum key distribution as well as simultaneous self-testing of multiple nodes in quantum networks.

123 a "Virus Pod" (V-Pod) that enables sensitive self-testing of SARS-CoV-2 viral load in saliva.

124 hich enables direct, rapid, and multianalyte self-testing of the main DRDs (flunitrazepam, scopolamin

125 a microfluidic system that enables multiplex self-testing of urea, potassium, sodium, and chloride.

126 overage in the same manner as documented for self-testing of, for example, HIV, hepatitis C virus, an

127 HIV self-testing offers an approach to scaling up testing th

128 This analysis suggests that introducing self-testing offers some health benefits and may well sa

129 Among Malawian adults offered HIV self-testing, optional home initiation of care compared

130 esting option, including remote testing (HIV self-testing or HIV self-sampling), in the UK, a country

131 ividuals the choice of HIV testing using HIV self-testing or routine door-to-door HIV testing service

132 ted previously known benefits of at-home STI self-testing or specimen self-collection and accelerated

133 tests detecting antibodies, blood-based HIV self-testing, or oral fluid HIV self-testing.

134 morning HIV testing), and facility-based HIV self-testing (Oraquick HIV self-test, group demonstratio

135 se results do not support the superiority of self-testing over clinic testing in reducing the risk of

136 y novel methods to monitor CMV viremia using self-testing platforms.

137 randomly allocated (1:1) to either oral HIV self-testing plus routine door-to-door HIV testing servi

138 s further consideration as countries develop self-testing policies and programmes.

139 inic workflows, blood glucose monitoring and self-testing practices, and potential benefits and limit

140 nable consideration of developing formalized self-testing programs.

141 . genotype-guided warfarin dosing, patient's self-testing [PST] or patient's self-management [PSM] an

142 idence interval (CI) = 47-54%) and home with self-testing reached the highest proportion of young adu

143 Device-independent self-testing refers to the most complete such certificat

144 Secondary outcomes were uptake of HIV self-testing, reporting of positive HIV self-test result

145 HIV self-testing scale-up among key populations was estimate

146 o and during 2019-28 and 2019-38 for the HIV self-testing scale-up scenario.

147 and at the end of 2028 and 2038 for the HIV self-testing scale-up scenario.

148 ertainty intervals 0.4-0.9) in the blood HIV self-testing scenario and 0.8% (0.6-1.0) in the oral HIV

149 scenario and 0.8% (0.6-1.0) in the oral HIV self-testing scenario, compared with 0.3% (0.2-0.3) in t

150 Facility-based HIV self-testing should be considered for scale-up in settin

151 voluntary medical male circumcision post HIV self-testing show no statistically significant differenc

152 ffected by HIV/HCV co-infection can use this self-testing solution to track their viral loads on thei

153 Syphilis self-testing (SST) has potential to increase testing and

154 Syphilis self-testing (SST) may complement and extend facility-ba

155 quent UA measurements rely on blood-based UA self-testing strips.

156 In this paper, we consider the aspects of self-testing that merit its integration into HIV testing

157 IGN, SETTING, AND PARTICIPANTS: The COVID-19 Self-Testing Through Rapid Network Distribution study wa

158 (n = 16,660) who received access to home HIV self-testing through resident volunteers.

159 Policy makers should consider leveraging HIV self-testing to expand PrEP access among those at HIV ri

160 A fast and accurate self-testing tool for COVID-19 diagnosis has become a pr

161 We aimed to evaluate the impact of HIV self-testing use for PrEP scale-up.

162 testing (NAT) device towards streamlined HIV self-testing using 100 muL finger-prick whole blood.

163 1-55] years; 156 [56.1%] men) had at least 1 self-testing visit.

164 analyses, assessed among participants with 2 self-testing visits, compared the second self-test visit

165 Home self-testing was deemed beneficial, but the need for reg

166 Although HIV self-testing was first considered >20 years ago, it has

167 Self-testing was first demonstrated for the singlet stat

168 Uptake of HIV self-testing was high in both the home (5287/8194, 64.9%

169 Two adverse events related to HIV self-testing were reported: interpersonal violence and m

170 HIV self-testing, which has been increasingly available sinc

171 ucted a review of policy and research on HIV self-testing, which indicates that policy is shifting to

172 Home self-testing with LFIAs can be used with a high degree o

173 Self-testing with the NVHO can produce high quality imag

174 Scaling up HIV self-testing would avert 16.2% (90% UI 10.0-23.1) of all

175 Home-based testing combined with self-testing would have the greatest impact, increasing

176 We predict that the introduction of self-testing would lead to modest savings in healthcare

177 In HIV self-testing zones, trained lay-counsellors (known as co